In this edition, FDA places hold on cell therapy trial after patient death, selpercatinib delivers superior outcomes and more. Read the full coverage here: FDA places hold on trial of cell therapy for lung cancer after patient death Selpercatinib delivers superior outcomes, may ‘reduce the burden of NSCLC’ First-line immunotherapy benefits patients of all races with NSCLC equally Never-smoker lung cancer survivors require targeted surveillance Cemiplimab plus chemotherapy improves outcomes in metastatic NSCLC References: Baramidze A, et al. Abstract 1495P. Presented at: European Society for Medical Oncology Congress; Oct. 20-24, 2023; Madrid. Choi E, et al. JAMA Netw. Open. 2023;doi:10.1001/jamanetworkopen.2023.43278. Lee M, et al. J. Natl Compr Canc Netw. 2023;doi:10.6004/jnccn.2023.7064 Press Release Zhou C, et al. N Engl J Med. 2023;doi:10.1056.NEJMoa2309457.

In this edition, an advocacy group petitions the FDA for stronger safety warnings for Botox, melanoma regression is associated with improved prognosis and more. Read the full coverage here: Advocacy group petitions FDA for stronger safety warnings for Botox, related drugs Melanoma regression associated with improved prognosis Phase 4 results show Vtama cream efficacious in head, neck plaque psoriasis Isotretinoin not associated with increased risk for suicide, psychiatric conditions Tape strips may identify hidradenitis suppurativa in lesional, nonlesional skin References: Navrazhina K, et al. J Am Acad Dermatol. 2023;doi:10.1016/j.jaad.2023.11.048. Press Release Press Release Tan NKW, et al. JAMA Dermatol. 2023;doi:10.1001/jamadermatol.2023.4579. Wagner NB, et al. J Am Acad Dermatol. 2023;doi:10.1016/j.jaad.2023.11.040.

In this edition, allergic illnesses in children may be inherited from mothers; addressing needs of Muslim patients in dermatology; YouTube content on topical steroid withdrawal exhibits poor reliability and more. Read the full coverage here: Atopic dermatitis, other allergic illnesses in children may be inherited from mothers Addressing needs of Muslim patients in dermatology YouTube content on topical steroid withdrawal exhibits poor reliability, quality RelabotulinumtoxinA demonstrates rapid onset, durability for frown lines, crow’s feet Puberty, skin of color, weight associated with acne prevalence among adolescents References: Chiesa Fuxench ZC, et al. J Am Acad Dermatol. 2023;doi:10.1016/j.jaad.2023.11.013. El-Banna G, et al. JAMA Dermatol. 2023;doi:10.1001/jamadermatol.2023.4439. McCormick E, et al. J Drugs Dermatol. 2023;doi:10.36849/JDD.C7443. Press Release Witkam WCAM, et al. J Am Acad Dermatol. 2023;doi:10.1016/j.jaad.2023.10.062.

In this edition, dermatologists ‘uniquely positioned’ to aid human trafficking victims; FDA approves Cosentyx for hidradenitis suppurativa and more. Read the full coverage here: Dermatologists ‘uniquely positioned’ to recognize, aid human trafficking victims FDA approves Cosentyx as first IL-17A inhibitor for hidradenitis suppurativa FDA approves Stelara biosimilar for treatment of psoriasis, multiple inflammatory diseases RECELL system efficacious in vitiligo repigmentation Isotretinoin efficacious in seborrheic dermatitis treatment References: Elbuluk N. Optimizing melanocyte cell transplant procedure for treatment of vitiligo. Presented at: American Society for Dermatologic Surgery Annual Meeting; Nov 1-5, 2023; Chicago. Kourosh S. The role of dermatologic surgeons in advocating for those affected by human trafficking. Presented at: American Society for Dermatologic Surgery Annual Meeting; Nov 1-5, 2023; Chicago. Press Release Press Release Tan MG, et al. Isotretinoin for the management of moderate to severe seborrheic dermatitis. Presented at: American Society for Dermatologic Surgery Annual Meeting; Nov 1-5, 2023; Chicago.

In this edition, multicancer detection tests show promise; lifestyle counseling appointments benefit cancer survivors; use of low-value drugs for patients with cancer, and more. Read the full coverage here: Multicancer detection tests show promise, but questions linger about their accessibility Shared medical appointments for lifestyle counseling benefit cancer survivors Industry payments to physicians spur use of low-value drugs for patients with cancer Study shows link between ultraprocessed foods and mortality risk Radiation oncologist appointed to leadership role at NYU Langone’s Perlmutter Cancer Center References: Mitchell AP, et al. BMJ. 2023;doi:10.1136/bmj-2023-075512. Press Release Westgate C, Fischer J. What primary care physicians need to know about multicancer early detection tests. Presented at: OMED; Oct. 5-8, 2023. Winters LN. The development of an advanced practice nurse and registered dietician-led lifestyle medicine shared medical appointment program for cancer survivors. Presented at: Lifestyle Medicine 2023; Denver; Oct. 29-Nov. 1, 2023. Zhao Y, et al. Am J Prev Med. 2023;doi:10.1016/j.amepre.2023.09.005.

In this edition, FDA approves Bimzelx for plaque psoriasis; roflumilast foam improves quality of life in patients with seborrheic dermatitis and more. Read the full coverage here: FDA approves Bimzelx for treatment of moderate to severe plaque psoriasis Roflumilast foam improves quality of life in patients with seborrheic dermatitis Opzelura effective, well tolerated in children aged at least 2 years with atopic dermatitis Treatment for onychomycosis prescribed at only 20% of visits, impacting quality of life Study: Important to weigh berdazimer gel benefits vs. risks in molluscum contagiosum References: Calvi IP, et al. Pediatr Dermatol. 2023;doi:10.1111/pde.15419. Chu D. et al. Poster. Effect of roflumilast foam 0.3% on quality of life in patients with seborrheic dermatitis: patient-reported outcomes from the STRATUM phase III trial. Presented at: AMCP Nexus; Orlando. Peck GM, et al. J Drugs Dermatol. 2023;doi:10.36849/JDD.6770. Press Release Press Release

In this edition, FDA issues complete response letter for relabotulinumtoxinA; mucocutaneous manifestations may signal COVID-induced inflammatory disease in children and more. Read the full coverage here: FDA issues complete response letter for relabotulinumtoxinA for frown lines, crow’s feet Mucocutaneous manifestations may signal COVID-induced inflammatory disease in children FDA approves Zoryve for pediatric psoriasis Colloidal oatmeal, prescription cream comparable in Black children with atopic dermatitis FDA issues complete response letter for lebrikizumab for eczema treatment References: Imam B. Mucocutaneous clinical manifestation of multi-system inflammatory syndrome in children (MIS-C). Presented at: Skin of Color Update; Oct. 6-8, 2023; New York. Lisante TA, et al. J Dermatolog Treat. 2023;doi:10.1080/09546634.2023.2241587. Press Release Press Release Press Release

In this edition, precision navigators reduce racial disparities in genomic testing; cancer diagnoses fell sharply during early days of pandemic; Prostate Cancer Awareness Month updates, and more. Read the full coverage here: Precision navigators reduce racial disparities in genomic testing for prostate cancer Cancer diagnoses fell sharply during early days of pandemic, NCI report shows Prostate Cancer Awareness Month: Financial hardship common, exercise beneficial Researchers identify 11 genes linked to aggressive prostate cancer Black men less likely to receive targeted therapy for metastatic prostate cancer References: Allen AJ, et al. Abstract 122. Presented at: ASTRO Annual Meeting; Oct. 1-4, 2023; San Diego. Darst BF, et al. JAMA Oncol. 2023;doi:10.1001/jamaoncol.2023.3482. Healio Coverage Hwang C, et al. JAMA Netw Open. 2023;doi:10.1001/jamanetworkopen.2023.34208. Negoita S, et al. Cancer. 2023;doi:10.1002/cncr.35026.

In this edition, retinoids and OTC products for photoaged skin; fractional lasers show promise in skin cancer prevention; a botanical drug for severe thermal burns and more. Read the full coverage here: Prescription retinoids, OTC products positively impact photoaged skin Fractional lasers show promise in skin cancer prevention Botanical drug may outperform standard of care for treatment of severe thermal burns 5-fluorouracil cream noninferior to surgery for Bowen’s disease Perifollicular linear projections aid in early diagnosis of facial lentigo maligna References: Ahmady S, et al. J Am Acad Dermatol. 2023;doi:10.1016/j.jaad.2023.08.076. McCormick ET, et al. J Drugs Dermatol. 2023;doi:10.36849/JDD.2023.NVRN0923. Navarrete-Dechent C, et al. J Am Acad Dermatol. 2023;doi:10.1016/j.jaad.2023.07.1036. Press Release Sadick N, et al. J Drugs Dermatol. 2023;doi:10.36849/JDD.7753.

In this edition, CDC issues a health advisory concerning flesh-eating bacterium, staging for melanoma does not represent accurate recurrence and mortality and more. Read the full coverage here: CDC issues health advisory about recent reports of fatal Vibrio vulnificus Study finds melanoma treatment costs have increased, but so has survival Melanoma staging system inaccurately reflects recurrence, mortality risk Study: Nemolizumab shows promise as prurigo nodularis treatment Adverse events after ICI treatment linked to improved outcomes in patients with melanoma References: Bateni SB, et al. JAMA Dermatol. 2023;doi:10.1001/jamadermatol.2023.3179. Deng J, et al. JAMA Dermatol. 2023;doi:10.1001/jamadermatol.2023.2609. Du Y, et al. JAMA Dermatol. 2023;doi:10.1001/jamadermatol.2023.3003. Helvind NM, et al. JAMA Dermatol. 2023;doi:10.1001/jamadermatol.2023.3256. Press Release